Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Collaborations and capacities to transform fire management.

Schultz CA, Moseley C.

Science. 2019 Oct 4;366(6461):38-40. doi: 10.1126/science.aay3727. Epub 2019 Oct 3. No abstract available.

PMID:
31604295
2.

Medicaid and CHIP Child Health Beneficiary Incentives: Program Landscape and Stakeholder Insights.

Moseley CA, Vulimiri M, Saunders RS, Bleser WK, Perrin EM, Armstrong SC, Wang GX, Ubel PA, McClellan M, Wong CA.

Pediatrics. 2019 Aug;144(2). pii: e20183161. doi: 10.1542/peds.2018-3161. Epub 2019 Jul 9.

PMID:
31289193
3.

Correlation of DOTATOC Uptake and Pathologic Grade in Neuroendocrine Tumors.

Chan H, Moseley C, Zhang L, Bergsland EK, Pampaloni MH, Van Loon K, Hope TA.

Pancreas. 2019 Aug;48(7):948-952. doi: 10.1097/MPA.0000000000001356.

PMID:
31268975
4.

Adolescent and Young Adult Recreational, Occupational, and Transportation Activity: Activity Recommendation and Weight Status Relationships.

Moseley CA, Skinner AC, Perrin EM, Armstrong SC, Peterson ED, Wong CA.

J Adolesc Health. 2019 Jul;65(1):147-154. doi: 10.1016/j.jadohealth.2019.01.021. Epub 2019 Apr 1.

PMID:
30948270
5.

Engaging Beneficiaries In Medicaid Programs That Incentivize Health-Promoting Behaviors.

Vulimiri M, Bleser WK, Saunders RS, Madanay F, Moseley C, McGuire HF, Ubel PA, McKethan A, McClellan M, Wong CA.

Health Aff (Millwood). 2019 Mar;38(3):431-439. doi: 10.1377/hlthaff.2018.05427.

PMID:
30830831
6.

A cluster randomized trial of strategies to increase uptake amongst young women invited for their first cervical screen: The STRATEGIC trial.

Kitchener H, Gittins M, Cruickshank M, Moseley C, Fletcher S, Albrow R, Gray A, Brabin L, Torgerson D, Crosbie EJ, Sargent A, Roberts C.

J Med Screen. 2018 Jun;25(2):88-98. doi: 10.1177/0969141317696518. Epub 2017 May 22.

7.

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination.

Evonuk KS, Moseley CE, Doyle RE, Weaver CT, DeSilva TM.

J Vis Exp. 2016 Sep 12;(115). doi: 10.3791/54348.

8.

Airway and peripheral urokinase plasminogen activator receptor is elevated in asthma, and identifies a severe, nonatopic subset of patients.

Portelli MA, Moseley C, Stewart CE, Postma DS, Howarth P, Warner JA, Holloway JW, Koppelman GH, Brightling C, Sayers I.

Allergy. 2017 Mar;72(3):473-482. doi: 10.1111/all.13046. Epub 2016 Oct 5.

PMID:
27624865
9.

Racial and Insurance Status Disparities in Patient Safety Indicators among Hospitalized Patients.

Shen JJ, Cochran CR, Mazurenko O, Moseley CB, Shan G, Mukalian R, Neishi S.

Ethn Dis. 2016 Jul 21;26(3):443-52. doi: 10.18865/ed.26.3.443.

10.

Evaluation of Brace Treatment for Infant Hip Dislocation in a Prospective Cohort: Defining the Success Rate and Variables Associated with Failure.

Upasani VV, Bomar JD, Matheney TH, Sankar WN, Mulpuri K, Price CT, Moseley CF, Kelley SP, Narayanan U, Clarke NM, Wedge JH, Castañeda P, Kasser JR, Foster BK, Herrera-Soto JA, Cundy PJ, Williams N, Mubarak SJ.

J Bone Joint Surg Am. 2016 Jul 20;98(14):1215-21. doi: 10.2106/JBJS.15.01018.

PMID:
27440570
11.

T cell cytokine signatures: Biomarkers in pediatric multiple sclerosis.

Cala CM, Moseley CE, Steele C, Dowdy SM, Cutter GR, Ness JM, DeSilva TM.

J Neuroimmunol. 2016 Aug 15;297:1-8. doi: 10.1016/j.jneuroim.2016.04.015. Epub 2016 Apr 30.

12.

A Practical Approach to Determining the Center of the Femoral Head in Subluxated and Dislocated Hips.

Cuomo AV, Fedorak GT, Moseley CF.

J Pediatr Orthop. 2015 Sep;35(6):556-60. doi: 10.1097/BPO.0000000000000281.

PMID:
26090988
13.

Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination.

Evonuk KS, Baker BJ, Doyle RE, Moseley CE, Sestero CM, Johnston BP, De Sarno P, Tang A, Gembitsky I, Hewett SJ, Weaver CT, Raman C, DeSilva TM.

J Immunol. 2015 Jul 15;195(2):450-463. doi: 10.4049/jimmunol.1401108. Epub 2015 Jun 12.

14.

The rotary zone thermal cycler: a low-power system enabling automated rapid PCR.

Bartsch MS, Edwards HS, Lee D, Moseley CE, Tew KE, Renzi RF, Van de Vreugde JL, Kim H, Knight DL, Sinha A, Branda SS, Patel KD.

PLoS One. 2015 Mar 31;10(3):e0118182. doi: 10.1371/journal.pone.0118182. eCollection 2015.

15.

Molecular phenotyping of a UK population: defining the human serum metabolome.

Dunn WB, Lin W, Broadhurst D, Begley P, Brown M, Zelena E, Vaughan AA, Halsall A, Harding N, Knowles JD, Francis-McIntyre S, Tseng A, Ellis DI, O'Hagan S, Aarons G, Benjamin B, Chew-Graham S, Moseley C, Potter P, Winder CL, Potts C, Thornton P, McWhirter C, Zubair M, Pan M, Burns A, Cruickshank JK, Jayson GC, Purandare N, Wu FC, Finn JD, Haselden JN, Nicholls AW, Wilson ID, Goodacre R, Kell DB.

Metabolomics. 2015;11:9-26. Epub 2014 Jul 25.

16.

State policies and practices in behavior supports for persons with intellectual and developmental disabilities in the United States: a national survey.

Rotholz DA, Moseley CR, Carlson KB.

Intellect Dev Disabil. 2013 Dec;51(6):433-45. doi: 10.1352/1934-9556-51.6.433.

PMID:
24447015
17.

Using research evidence to inform public policy decisions.

Moseley C, Kleinert H, Sheppard-Jones K, Hall S.

Intellect Dev Disabil. 2013 Oct;51(5):412-22. doi: 10.1352/1934-9556-51.5.412. Review.

PMID:
24303827
18.

Evaluation of potential PET imaging probes for the orexin 2 receptors.

Wang C, Wilson CM, Moseley CK, Carlin SM, Hsu S, Arabasz G, Schroeder FA, Sander CY, Hooker JM.

Nucl Med Biol. 2013 Nov;40(8):1000-5. doi: 10.1016/j.nucmedbio.2013.07.001. Epub 2013 Aug 15.

19.

Safety, tolerability, pharmacokinetics, and antiviral activity of GSK2336805, an inhibitor of hepatitis C virus (HCV) NS5A, in healthy subjects and subjects chronically infected with HCV genotype 1.

Wilfret DA, Walker J, Adkison KK, Jones LA, Lou Y, Gan J, Castellino S, Moseley CL, Horton J, de Serres M, Culp A, Goljer I, Spreen W.

Antimicrob Agents Chemother. 2013 Oct;57(10):5037-44. doi: 10.1128/AAC.00910-13. Epub 2013 Jul 29.

20.

Covert dyskinesia associated with aripiprazole: a case report and review of the literature.

Moseley CN, Simpson-Khanna HA, Catalano G, Catalano MC.

Clin Neuropharmacol. 2013 Jul-Aug;36(4):128-30. doi: 10.1097/WNF.0b013e31829b99d9. Review.

PMID:
23860346
21.

FDG-PET imaging reveals local brain glucose utilization is altered by class I histone deacetylase inhibitors.

Schroeder FA, Chonde DB, Riley MM, Moseley CK, Granda ML, Wilson CM, Wagner FF, Zhang YL, Gale J, Holson EB, Haggarty SJ, Hooker JM.

Neurosci Lett. 2013 Aug 29;550:119-24. doi: 10.1016/j.neulet.2013.06.016. Epub 2013 Jun 25.

22.

Radiosynthesis and evaluation of [11C]EMPA as a potential PET tracer for orexin 2 receptors.

Wang C, Moseley CK, Carlin SM, Wilson CM, Neelamegam R, Hooker JM.

Bioorg Med Chem Lett. 2013 Jun 1;23(11):3389-92. doi: 10.1016/j.bmcl.2013.03.079. Epub 2013 Apr 2.

23.

Application of palladium-mediated (18)F-fluorination to PET radiotracer development: overcoming hurdles to translation.

Kamlet AS, Neumann CN, Lee E, Carlin SM, Moseley CK, Stephenson N, Hooker JM, Ritter T.

PLoS One. 2013;8(3):e59187. doi: 10.1371/journal.pone.0059187. Epub 2013 Mar 12.

24.

Synthesis and evaluation of methylated arylazepine compounds for PET imaging of 5-HT(2c) receptors.

Granda ML, Carlin SM, Moseley CK, Neelamegam R, Mandeville JB, Hooker JM.

ACS Chem Neurosci. 2013 Feb 20;4(2):261-5. doi: 10.1021/cn300223d. Epub 2012 Dec 7.

25.

Correlates of everyday choice and support-related choice for 8,892 randomly sampled adults with intellectual and developmental disabilities in 19 states.

Tichá R, Lakin KC, Larson SA, Stancliffe RJ, Taub S, Engler J, Bershadsky J, Moseley C.

Intellect Dev Disabil. 2012 Dec;50(6):486-504. doi: 10.1352/1934-9556-50.06.486.

PMID:
23256691
26.

An efficient and practical radiosynthesis of [11C]temozolomide.

Moseley CK, Carlin SM, Neelamegam R, Hooker JM.

Org Lett. 2012 Dec 7;14(23):5872-5. doi: 10.1021/ol302791x. Epub 2012 Nov 14. Erratum in: Org Lett. 2013 Feb 15;15(4):973.

27.

Place of residence and preventive health care for intellectual and developmental disabilities services recipients in 20 states.

Bershadsky J, Taub S, Engler J, Moseley CR, Lakin KC, Stancliffe RJ, Larson S, Ticha R, Bailey C, Bradley V.

Public Health Rep. 2012 Sep-Oct;127(5):475-85.

28.

Evidence-based medicine: not a slam dunk.

Moseley CF.

J Pediatr Orthop. 2012 Sep;32 Suppl 2:S111-3. doi: 10.1097/BPO.0b013e31824b2558.

PMID:
22890448
29.

Initial implementation indicators from a statewide rollout of SafeCare within a child welfare system.

Whitaker DJ, Ryan KA, Wild RC, Self-Brown S, Lutzker JR, Shanley JR, Edwards AM, McFry EA, Moseley CN, Hodges AE.

Child Maltreat. 2012 Feb;17(1):96-101. doi: 10.1177/1077559511430722. Epub 2011 Dec 5.

30.

Hospital financial position and the adoption of electronic health records.

Ginn GO, Shen JJ, Moseley CB.

J Healthc Manag. 2011 Sep-Oct;56(5):337-50; discussion 351-2.

PMID:
21991681
31.

Trends of increase in western medical services in traditional medicine hospitals in China.

Shen JJ, Wang Y, Lin F, Lu J, Moseley CB, Sun M, Hao M.

BMC Health Serv Res. 2011 Sep 6;11:212. doi: 10.1186/1472-6963-11-212.

32.

Regional disparities in prenatal care services in rural China.

Lu J, Shen JJ, Chen G, Moseley CB, Sun M, Gao F, Wang Y, Mao Y, Hao M.

Asia Pac J Public Health. 2011 Sep;23(5):682-9. doi: 10.1177/1010539511418356. Epub 2011 Aug 18.

PMID:
21852422
33.

Risk factors for failure after open reduction for DDH: a matched cohort analysis.

Sankar WN, Young CR, Lin AG, Crow SA, Baldwin KD, Moseley CF.

J Pediatr Orthop. 2011 Apr-May;31(3):232-9. doi: 10.1097/BPO.0b013e31820c9b31.

PMID:
21415680
34.

Characteristics of acute care hospitals with diversity plans and translation services.

Moseley CB, Shen JJ, Ginn GO.

J Healthc Manag. 2011 Jan-Feb;56(1):45-61; discussion 61-2.

PMID:
21323027
35.

Association of cognitive performance with the metabolic syndrome and with glycaemia in middle-aged and older European men: the European Male Ageing Study.

Tournoy J, Lee DM, Pendleton N, O'Neill TW, O'Connor DB, Bartfai G, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Moseley CM, Punab M, Silman AJ, Vanderschueren D, Wu FC, Boonen S; EMAS study group.

Diabetes Metab Res Rev. 2010 Nov;26(8):668-76. doi: 10.1002/dmrr.1144.

PMID:
21043047
36.

Femoral head sphericity in untreated developmental dislocation of the hip.

Sankar WN, Neubuerger CO, Moseley CF.

J Pediatr Orthop. 2010 Sep;30(6):558-61. doi: 10.1097/BPO.0b013e3181e4f53e.

PMID:
20733420
37.

Peroxisome proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal influenza virus challenge in mice.

Moseley CE, Webster RG, Aldridge JR.

Influenza Other Respir Viruses. 2010 Sep;4(5):307-11. doi: 10.1111/j.1750-2659.2010.00155.x.

38.

Chronic widespread pain is associated with slower cognitive processing speed in middle-aged and older European men.

Lee DM, Pendleton N, Tajar A, O'Neill TW, O'Connor DB, Bartfai G, Boonen S, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Punab M, Silman AJ, Vanderschueren D, Moseley CM, Wu FC, McBeth J; EMAS Study Group.

Pain. 2010 Oct;151(1):30-6. doi: 10.1016/j.pain.2010.04.024. Epub 2010 Jun 19.

PMID:
20646831
39.

Unilateral proximal bifurcation of the femur.

Osuji CK, Chafik D, Moseley CF.

J Pediatr Orthop. 2009 Oct-Nov;29(7):695-7. doi: 10.1097/BPO.0b013e3181b76985.

PMID:
20104147
40.

Femoral anteversion in developmental dysplasia of the hip.

Sankar WN, Neubuerger CO, Moseley CF.

J Pediatr Orthop. 2009 Dec;29(8):885-8. doi: 10.1097/BPO.0b013e3181c1e961.

PMID:
19934704
41.

Predictors of the need for femoral shortening osteotomy during open treatment of developmental dislocation of the hip.

Sankar WN, Tang EY, Moseley CF.

J Pediatr Orthop. 2009 Dec;29(8):868-71. doi: 10.1097/BPO.0b013e3181c29cb2.

PMID:
19934701
42.

Evidence-based medicine: the dark side: POSNA 2008 presidential guest lecture.

Moseley C.

J Pediatr Orthop. 2009 Dec;29(8):839-43. doi: 10.1097/BPO.0b013e3181c1e527. No abstract available.

PMID:
19934694
43.

Community orientation and the strategic posture of hospitals.

Ginn GO, Shen JJ, Moseley CB.

Hosp Top. 2009 Summer;87(3):11-7. doi: 10.3200/HTPS.87.3.11-18.

PMID:
19454398
44.

Community benefit laws, hospital ownership, community orientation activities, and health promotion services.

Ginn GO, Shen JJ, Moseley CB.

Health Care Manage Rev. 2009 Apr-Jun;34(2):109-18. doi: 10.1097/HMR.0b013e31819e90e0.

PMID:
19322042
45.

TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection.

Aldridge JR Jr, Moseley CE, Boltz DA, Negovetich NJ, Reynolds C, Franks J, Brown SA, Doherty PC, Webster RG, Thomas PG.

Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5306-11. doi: 10.1073/pnas.0900655106. Epub 2009 Mar 11.

46.

Mental health services availability and admission of the seriously mentally ill from the emergency department.

Moseley C, Shen J, Cochran C.

J Health Hum Serv Adm. 2008 Winter;31(3):292-308.

PMID:
19209561
47.

From the emergency department to the general hospital: hospital ownership and market factors in the admission of the seriously mentally ill.

Shen JJ, Cochran CR, Moseley CB.

J Healthc Manag. 2008 Jul-Aug;53(4):268-79; discussion 279-80.

PMID:
18720688
48.

Forest restoration and forest communities: have local communities benefited from forest service contracting of ecosystem management?

Moseley C, Reyes YE.

Environ Manage. 2008 Aug;42(2):327-43. doi: 10.1007/s00267-008-9116-4. Epub 2008 Jun 3.

PMID:
18521660
49.

Incarceration and risky sexual partnerships in a southern US city.

Khan MR, Wohl DA, Weir SS, Adimora AA, Moseley C, Norcott K, Duncan J, Kaufman JS, Miller WC.

J Urban Health. 2008 Jan;85(1):100-13. Epub 2007 Nov 20.

50.

National core indicators: ten years of collaborative performance measurement.

Bradley VJ, Moseley C.

Intellect Dev Disabil. 2007 Oct;45(5):354-8. No abstract available.

PMID:
17887913

Supplemental Content

Loading ...
Support Center